Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5 P30 CA06516
National Institutes of Health
Grant: R01-CA180692
Damon Runyon-Sohn
Grant: DRSG-24-18
NCI NIH HHS
Grant: P30 CA006516
NCI NIH HHS
Grant: R01 CA180692
NCI NIH HHS
Grant: R35 CA210064
NCI NIH HHS
Grant: K08 CA245251
National Institutes of Health
Grant: 3P30CA006516-41S6
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5R01CA180692-05
Role of LMO1 in Neuroblastoma Initiation and Maintenance
American Society of Clinical Oncology
Rally Foundation for Childhood Cancer Research
Alex’s Lemonade Stand Foundation for Childhood Cancer
CureSearch for Children’s Cancer
Pediatric Cancer Research Foundation
Open Hands Overflowing Hearts
FWCI
1.09
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals